Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $69.69 USD
Change Today -1.07 / -1.51%
Volume 1.4M
AZN On Other Exchanges
Symbol
Exchange
New York
Xetra
London
Stockholm
OTC US
Mexico
Berlin
As of 3:09 PM 04/28/15 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - ASTRAZENECA PLC-SPONS ADR (AZN)

AstraZeneca PLC to Report Q3, 2015 on Nov 05, 2015
CapIQ 11/05/2015 5:00 AM ET
AstraZeneca PLC to Report Q2, 2015 on Jul 30, 2015
CapIQ 11/05/2015 5:00 AM ET
AstraZeneca PLC to Report Q1, 2015 on Apr 24, 2015
CapIQ 11/05/2015 5:00 AM ET

2013 revenues at AstraZeneca PLC totaled $25.7B USD, while annual earnings equaled $5.05 per share.

Quarterly Earnings & Estimates - ASTRAZENECA PLC-SPONS ADR (AZN)

Actuals vs. Estimates for ASTRAZENECA PLC-SPONS ADR AZN

AstraZeneca PLC's Quarterly Earnings

AstraZeneca PLC reported 2nd quarter 2014 earnings of $1.30 per share on 08/2/2014.

Annual Earnings & Estimates - ASTRAZENECA PLC-SPONS ADR (AZN)

Actuals vs. Estimates for ASTRAZENECA PLC-SPONS ADR AZN

AstraZeneca PLC's Annual Earnings

AstraZeneca PLC reported annual 2013 earnings of $5.05 per share on 02/8/2014.

Quarterly Revenues - ASTRAZENECA PLC-SPONS ADR (AZN)

Actuals vs. Estimates for ASTRAZENECA PLC-SPONS ADR AZN

AstraZeneca PLC's Quarterly Revenues

AstraZeneca PLC had 2nd quarter 2014 revenues of $6.5B USD. This bettered the $6.3B USD consensus of the 18 analysts covering the company. This was 3.6% above the prior year's 2nd quarter results.

Annual Revenues - ASTRAZENECA PLC-SPONS ADR (AZN)

Actuals vs. Estimates for ASTRAZENECA PLC-SPONS ADR AZN

AstraZeneca PLC's Annual Revenues

AstraZeneca PLC had revenues for the full year 2013 of $25.7B USD. This was -8.1% below the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AZN:US $69.69 USD -1.07

AZN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AbbVie Inc $66.21 USD +1.19
BASF SE €92.39 EUR -1.06
Biogen Inc $377.82 USD -11.45
Celgene Corp $113.74 USD -0.98
Eli Lilly & Co $71.20 USD +0.31
View Industry Companies
 

Industry Analysis

AZN

Industry Average

Valuation AZN Industry Range
Price/Earnings 70.9x
Price/Sales 3.5x
Price/Book 5.4x
Price/Cash Flow 70.8x
TEV/Sales 3.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ASTRAZENECA PLC-SPONS ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.